New Journal! Cell Reports Medicine

Posted on May 1, 2020 by Ryan

Cell Reports Medicine is a new open-access journal published by Cell Press. The aims and scope are “publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.”

The journal publishes original research on topics and concepts such as translational studies, clinical trials, biomarker discovery, technologic advancements in healthcare, human biology, disease, and all phases of clinical work. This journal is now available via the Library’s OneSearch catalog.

Select Mechanisms of Stopping Cancer Development and Cancer Recurrence and More

Posted on April 29, 2020 by Marina

Research conducted by a group of scientists from different institutions led by the University of Michigan Rogel Cancer Center has identified a key braking mechanism that could potentially halt the runaway growth of many different types of cancer. The scientists achieved a precise understanding, which was lacking in previous research, of how the activity of PP2A, an enzyme produced by the body and capable of halting the tumor growth, is increased by small molecule activators of PP2A (SMAP), specifically, by DT-061 SMAP. This breakthrough discovery can be potentially used in developing new promising treatments. The study is due to be published in Cell.
Researchers from Francis Crick Institute (London, UK) identified an experimental drug instrumental in preventing cancers from recurrence. The drug. Quisinostat, could stop tumor re-growth after initial treatment in live mice and prevent the expansion of surviving human cancer cells in culture. Quisinostat works by interfering with the cancer cells epigenetic state to stop them from self-renewal. The study has been published in Nature Communications.
Researchers from the University of Bayreuth (Germany) identified a natural protective mechanism against cancer that can develop as a result of the irregular distribution of genetic information to daughter cells. Their research focuses on the role of enzyme separase in cellular processes. The findings, which offer new approaches for cancer therapy, are published in Nature,
Researchers from the United States and Europe reported successful implementation of an Artificial Intelligence algorithm for stratifying the risk of indeterminate pulmonary nodules (IPNs). The use of Artificial Intelligence may lead to decreasing invasive procedures and reducing cancer diagnosis delays, which are crucial for timely cancer treatment. The study is due to be published in the American Journal of Respiratory and Critical Care Medicine.

A New PubMed is Coming: Are You Ready?

Posted on April 28, 2020 by Robin

In mid-May 2020, the new version of PubMed will officially replace Legacy PubMed. Learn more about what changes you can expect in our original blog post on this topic.

A new user guide answers many common questions about how best to use the new site. NLM has added links on the new PubMed homepage to many popular PubMed features including the Advanced Search and the MeSH database.

The University of Texas Libraries have created a guide to help PubMed users transition between the Legacy PubMed to the new version. It includes side-by-side text and/or images illustrating how to use common features in the Legacy PubMed and where to find these features in New PubMed. These comparisons show the desktop versions of PubMed. New PubMed is intended to be used with a variety of different devices and features a mobile-friendly search.

In May, our Research Informationists will be offering New PubMed workshops (via Zoom or WebEx) to help you transition to using PubMed 2.0. Register now:

As always, if you have questions or need help with the new PubMed, please Ask Us!

MSK Library Blog

Sharing Research, Resources & News

New Journal! Cell Reports Medicine

Select Mechanisms of Stopping Cancer Development and Cancer Recurrence and More

A New PubMed is Coming: Are You Ready?

msklibrary